Your browser is no longer supported. Please, upgrade your browser.
IART [NASD]
Integra LifeSciences Holdings Corporation
Index- P/E29.96 EPS (ttm)2.42 Insider Own12.60% Shs Outstand84.69M Perf Week5.68%
Market Cap6.01B Forward P/E21.19 EPS next Y3.42 Insider Trans-9.84% Shs Float72.66M Perf Month6.08%
Income205.50M PEG1.69 EPS next Q0.73 Inst Own90.10% Short Float5.87% Perf Quarter-2.28%
Sales1.51B P/S3.98 EPS this Y170.70% Inst Trans0.44% Short Ratio11.77 Perf Half Y9.62%
Book/sh18.60 P/B3.89 EPS next Y13.79% ROA5.70% Target Price77.55 Perf Year48.22%
Cash/sh4.79 P/C15.12 EPS next 5Y17.73% ROE13.70% 52W Range42.12 - 77.40 Perf YTD11.51%
Dividend- P/FCF21.33 EPS past 5Y73.70% ROI5.50% 52W High-6.47% Beta1.23
Dividend %- Quick Ratio2.20 Sales past 5Y9.20% Gross Margin64.30% 52W Low71.87% ATR2.21
Employees3700 Current Ratio3.20 Sales Q/Q50.80% Oper. Margin12.20% RSI (14)63.11 Volatility4.61% 2.89%
OptionableYes Debt/Eq0.98 EPS Q/Q394.50% Profit Margin13.60% Rel Volume1.37 Prev Close71.09
ShortableYes LT Debt/Eq0.95 EarningsJul 28 BMO Payout0.00% Avg Volume362.56K Price72.39
Recom2.40 SMA205.66% SMA505.02% SMA20011.29% Volume498,178 Change1.83%
Oct-08-20Downgrade JP Morgan Neutral → Underweight $55 → $50
May-27-20Initiated Citigroup Neutral $54
Apr-03-20Initiated SunTrust Buy $55
Jan-07-20Downgrade Piper Sandler Overweight → Neutral $59 → $58
Jan-07-20Downgrade Piper Jaffray Overweight → Neutral $59 → $58
Jan-03-19Initiated SunTrust Buy $56
Nov-28-18Initiated UBS Neutral $58
Aug-07-18Downgrade BofA/Merrill Neutral → Underperform
Jul-26-18Upgrade BTIG Research Neutral → Buy $69
Jul-02-18Downgrade Citigroup Buy → Neutral
Jan-05-18Resumed Cantor Fitzgerald Neutral
Jan-02-18Downgrade BofA/Merrill Buy → Neutral
Nov-09-17Reiterated RBC Capital Mkts Sector Perform $48 → $50
Oct-30-17Downgrade Wells Fargo Outperform → Market Perform
Oct-27-17Downgrade JP Morgan Overweight → Neutral
Jun-30-17Initiated Cantor Fitzgerald Overweight $65
May-02-17Reiterated RBC Capital Mkts Sector Perform $46 → $48
Jan-13-17Reiterated RBC Capital Mkts Sector Perform $85 → $46
Jan-06-17Upgrade JMP Securities Mkt Perform → Mkt Outperform
Dec-12-16Initiated UBS Buy $96
Jul-29-21 08:29AM  
Jul-28-21 02:00PM  
07:15AM  
06:00AM  
Jul-27-21 10:53AM  
Jul-21-21 03:02PM  
Jul-20-21 06:59AM  
Jul-19-21 04:30PM  
03:39AM  
Jul-15-21 08:27AM  
Jul-14-21 04:30PM  
Jul-08-21 08:30AM  
Jun-24-21 08:30AM  
Jun-13-21 04:44AM  
Jun-01-21 09:32AM  
May-28-21 11:32AM  
May-20-21 06:00AM  
May-08-21 03:59AM  
May-07-21 08:30AM  
Apr-30-21 10:04AM  
09:29AM  
09:01AM  
Apr-29-21 09:15AM  
09:04AM  
Apr-28-21 07:30PM  
07:30AM  
06:45AM  
06:00AM  
Apr-27-21 08:56AM  
Apr-22-21 10:59AM  
Apr-20-21 09:49AM  
08:09AM  
Apr-19-21 04:15PM  
Apr-08-21 04:00PM  
Apr-03-21 05:30AM  
Apr-01-21 04:15PM  
Mar-31-21 10:41AM  
09:08AM  
Mar-22-21 05:33AM  
Mar-20-21 11:30AM  
Mar-10-21 09:24AM  
Feb-25-21 11:36PM  
Feb-19-21 08:00AM  
Feb-18-21 04:00PM  
07:47AM  
06:30AM  
06:00AM  
Feb-12-21 07:50AM  
Feb-09-21 02:00AM  
Jan-21-21 09:29AM  
Jan-20-21 08:40AM  
Jan-15-21 08:35AM  
Jan-14-21 06:30AM  
Jan-06-21 01:30PM  
09:29AM  
Jan-05-21 10:02AM  
Jan-04-21 12:49PM  
Dec-31-20 09:26AM  
Dec-29-20 10:36AM  
Dec-26-20 03:33AM  
Dec-21-20 04:01PM  
Dec-16-20 08:00AM  
Dec-15-20 08:39PM  
Dec-08-20 12:46PM  
Nov-27-20 11:31AM  
Nov-11-20 08:28AM  
Oct-29-20 11:20AM  
Oct-28-20 05:30PM  
07:30AM  
07:21AM  
06:30AM  
06:00AM  
Oct-21-20 12:32PM  
Oct-14-20 11:40AM  
Oct-08-20 03:37AM  
Oct-07-20 10:42AM  
09:00AM  
07:30AM  
Oct-06-20 04:01PM  
Sep-29-20 11:56AM  
09:02AM  
08:00AM  
Sep-09-20 11:30AM  
Sep-02-20 04:01PM  
Aug-11-20 07:15AM  
12:00AM  
Aug-10-20 05:15PM  
04:01PM  
Aug-07-20 10:57AM  
08:46AM  
08:35AM  
Aug-03-20 12:31PM  
Jul-24-20 02:38PM  
Jul-22-20 08:00AM  
Jul-20-20 04:03PM  
Jul-15-20 08:56AM  
Jul-09-20 04:15PM  
Jun-16-20 05:52PM  
Jun-06-20 11:31AM  
May-30-20 12:51AM  
Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, orthopedics, and general surgery. It operates in two segments, Codman Specialty Surgical, and Orthopedics and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, hydrocephalus management systems, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as asset management software and support, and after-market services. It also sells approximately 40,000 instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices. In addition, the company provides regenerative technology products for the treatment of acute and chronic wounds; and surgical tissue repair products for hernia repair, peripheral nerve repair and protection, and tendon repair. Further, it offers skin and wound repair, bone and joint fixation implants in the upper and lower extremities, and bone grafts products. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Evoli LisaExecutive Vice President &CHROMay 10Option Exercise49.835,335265,85310,570May 11 04:31 PM
Evoli LisaExecutive Vice President &CHROMay 10Sale75.005,335400,1257,825May 11 04:31 PM
Coleman GlennExecutive Vice President & COOApr 16Option Exercise19.4125,658498,02257,714Apr 19 04:19 PM
Coleman GlennExecutive Vice President & COOApr 16Sale71.5025,6581,834,54732,056Apr 19 04:19 PM
Evoli LisaExecutive Vice President &CHROApr 14Option Exercise51.945,225271,40011,265Apr 15 04:11 PM
Coleman GlennExecutive Vice President & COOApr 14Sale70.504,002282,14132,056Apr 15 04:12 PM
Evoli LisaExecutive Vice President &CHROApr 14Sale70.006,306441,4207,825Apr 15 04:11 PM
Coleman GlennExecutive Vice President & COOApr 09Option Exercise19.4112,500242,62548,558Apr 12 04:35 PM
Coleman GlennExecutive Vice President & COOApr 09Sale70.0012,500875,00036,058Apr 12 04:35 PM
Coleman GlennExecutive Vice President & COOMar 29Option Exercise19.4112,500242,62548,558Mar 30 05:33 PM
Coleman GlennExecutive Vice President & COOMar 29Sale68.5015,5001,061,75036,058Mar 30 05:33 PM
ESSIG STUARTDirectorMar 18Sale68.14214,55314,619,6410Mar 22 04:13 PM
Tru St Partnership, L.P.10% OwnerMar 18Sale68.14730,00049,742,2009,090,930Mar 22 04:15 PM
Arduini Peter JPresident & CEOMar 13Option Exercise0.008980217,081Mar 16 04:22 PM
Mosebrook JeffreySVP, Fin & Princ Acct OfficerMar 02Sale68.701,05872,6845,586Mar 03 04:39 PM
McBreen Michael J.EVP & President, CSSMar 02Sale69.002,205152,14517,233Mar 03 04:19 PM
Schwartz EricEVP, Chief Legal Officer & SecMar 02Sale69.104,212291,03123,528Mar 03 04:12 PM
Schwartz EricEVP, Chief Legal Officer & SecFeb 25Sale69.522,288159,06229,409Mar 01 05:55 PM
DAVIS ROBERT T. JR.EVP & President, TTFeb 25Sale69.4824,9411,732,96319,794Feb 26 04:08 PM
Tru St Partnership, L.P.10% OwnerFeb 18Sale71.1570,2755,000,0669,820,930Mar 22 04:15 PM
Arduini Peter JPresident & CEOFeb 01Option Exercise15.7922,786359,791239,499Feb 03 04:09 PM
Arduini Peter JPresident & CEOFeb 01Sale66.1622,7861,507,442216,713Feb 03 04:09 PM
Arduini Peter JPresident & CEODec 18Option Exercise15.7945,000710,550261,713Dec 21 04:08 PM
Arduini Peter JPresident & CEODec 18Sale61.9745,0002,788,780216,713Dec 21 04:08 PM
Tru St Partnership, L.P.10% OwnerDec 17Sale60.77200,00012,154,0009,891,205Dec 21 04:09 PM
Coleman GlennExecutive Vice President & COONov 13Sale56.032,600145,66633,894Nov 17 04:13 PM
Murphy Raymond G.DirectorNov 12Sale53.162,839150,92143,196Nov 13 04:14 PM
Evoli LisaExecutive Vice President &CHRONov 09Option Exercise36.646,976255,62711,926Nov 10 04:10 PM
McBreen Michael J.EVP & President, CSSNov 09Sale55.552,500138,87119,438Nov 10 04:12 PM
Evoli LisaExecutive Vice President &CHRONov 09Sale52.387,730404,9027,502Nov 10 04:10 PM
Coleman GlennExecutive Vice President & COONov 09Sale55.159,400518,38436,494Nov 12 04:08 PM
Tru St Partnership, L.P.10% OwnerSep 17Sale46.97200,0009,394,00010,091,205Sep 21 04:34 PM
Mosebrook JeffreySVP, Fin & Princ Acct OfficerAug 13Sale51.6880741,7096,644Aug 14 04:12 PM
Coleman GlennExecutive Vice President & COOAug 11Sale52.275,000261,34345,894Aug 13 04:10 PM